Detalles de la búsqueda
1.
Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPEC.
Ann Surg Oncol
; 31(1): 556-566, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37940804
2.
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
Ann Surg Oncol
; 31(1): 594-604, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37831280
3.
2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma.
Ann Surg Oncol
; 30(12): 7803-7813, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481492
4.
Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes.
Ann Surg Oncol
; 30(1): 404-414, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094689
5.
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Ann Surg Oncol
; 29(6): 3405-3417, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34783946
6.
Force Sensing on Cells and Tissues by Atomic Force Microscopy.
Sensors (Basel)
; 22(6)2022 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35336366
7.
HIPEC Methodology and Regimens: The Need for an Expert Consensus.
Ann Surg Oncol
; 28(13): 9098-9113, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34142293
8.
Impact of Previous Gynecologic Surgical Procedures on Outcomes of Non-Gynecologic Peritoneal Malignancies Mimicking Ovarian Cancer: Less Is More?
Ann Surg Oncol
; 28(5): 2899-2908, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641011
9.
Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 28(6): 3332-3342, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974694
10.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'
Ann Surg Oncol
; 28(13): 9060-9070, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34057569
11.
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds.
Br J Cancer
; 123(4): 644-656, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32493992
12.
Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
Mod Pathol
; 33(2): 217-227, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570769
13.
Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
Ann Surg Oncol
; 27(1): 98-106, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31691116
14.
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer.
Int J Mol Sci
; 21(13)2020 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646060
15.
ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC.
Ann Surg Oncol
; 31(4): 2511-2512, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38219000
16.
ASO Visual Abstract: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
Ann Surg Oncol
; 31(3): 2017-2018, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37907699
17.
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
J Surg Oncol
; 119(3): 336-346, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30554404
18.
Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma.
Int J Mol Sci
; 20(22)2019 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31752449
19.
Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 25(2): 404-413, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29159742
20.
Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC.
Ann Surg Oncol
; 25(11): 3264-3270, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30051371